產(chǎn)品編號 | bs-43080P |
英文名稱 | Recombinant SARS-Cov-2 (Omicron, B.1.1.529) Spike RBD protein (G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H), C-His (HEK293) |
中文名稱 | 重組SARS冠狀病毒2 Omicron突變體蛋白Spike RBD(G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H ) |
別 名 | Recombinant SARS-Cov-2 (Omicron, B.1.1.529) Spike RBD protein (G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H), C-His (HEK293) |
理論分子量 | 26.9kDa |
檢測分子量 | 36 |
性 狀 | Lyophilized or Liquid |
濃 度 | >0.5 mg/ml |
序 列 | 319-537/1273 |
純 度 | >90% as determined by SDS-PAGE |
純化方法 | AC |
內(nèi)毒素 | Not analyzed |
表達系統(tǒng) | HEK293 cell |
活性 | Not tested |
標簽 | C-His |
緩 沖 液 | PBS (pH7.4). |
保存條件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
注意事項 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
產(chǎn)品介紹 |
The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct. Anti-SARS-CoV-2 Spike Protein S(IgM校準品) 特性:人源單抗(雙鏈抗體),親和力高,批次質(zhì)量穩(wěn)定 識別位置:新冠病毒S蛋白RBD區(qū)域 產(chǎn)品應用:ELISA、膠體金層析、化學發(fā)光等 儲存條件:-20℃保存,避免反復凍融。 |
產(chǎn)品圖片 |
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2μg/mL (100 μL/Well) can bind SARS-CoV-2 Spike RBD (G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H), His Tag (Cat: bs-43080P), the EC50 is 37ng/mL.
|
1、抗體溶解方法 | |
2、抗體修復方式 | |
3、常用試劑的配制 | |
4、免疫組化操作步驟 | |
5、免疫組化問題解答 | |
6、Western Blotting 操作步驟 | |
7、Western Blotting 問題解答 | |
8、關(guān)于肽鏈的設(shè)計 | |
9、多肽的溶解與保存 | |
10、酶標抗體效價測定程序 | |